A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.

NCT06844357 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

HCC

Interventions

DRUG: tirapazamine
PROCEDURE: Transarterial Embolization (TAE)
PROCEDURE: TACE

Sponsor

Zhejiang Raygene Pharmaceuticals Co., Ltd